Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Obstet Fertil Senol ; 47(1): 44-53, 2019 01.
Article in French | MEDLINE | ID: mdl-30573426

ABSTRACT

OBJECTIVES: The main objective of this study was to describe the ovulation rate in patients with polycystic ovary syndrome, treated with ovulation induction/intra-uterine insemination and follitropin alfa by gonadotrophins at a second attempt. METHODS: An observational, national and multicentre study was carried out: 51 French physicians (endocrinologists, gynaecologists) participated. Eligible patients were followed according to the usual clinical practices. The primary endpoint was the number of ovulations (spontaneous or triggered). Quality of life evaluation (by FertiQoL), compliance, and patient satisfaction were secondary endpoints. RESULTS: A total of 202 patients (mean age: 29.9 years; mean infertility: 2.9 years) were included: 78.4% met the Rotterdam definition. The ovulation rate was 93.3% (95% confidence interval [89.8; 96.8]%). At 12 weeks of gestation, 38 patients had an ongoing pregnancy. A difference of 10 points of the mean total FertiQoL score was observed between the two attempts. No patient reported missing injection. More than 9 in 10 patients said they were satisfied to very satisfied with the use of the pen injector for administration of follitropin alfa. Eight patients (4.0%) had hyperstimulation leading to cycle cancellation, and two patients (1.1%) reported ovarian hyperstimulation syndrome. CONCLUSIONS: At the second cycle of follitropin alfa stimulation, a high rate of ovulations, satisfactory compliance and tolerance profile associated with a change in quality of life were reported.


Subject(s)
Follicle Stimulating Hormone, Human/administration & dosage , Infertility, Female/etiology , Infertility, Female/therapy , Ovulation Induction/methods , Polycystic Ovary Syndrome/complications , Adult , Female , France , Gestational Age , Humans , Insemination, Artificial , Ovarian Hyperstimulation Syndrome/epidemiology , Ovulation Induction/adverse effects , Patient Satisfaction , Pregnancy , Recombinant Proteins/administration & dosage
2.
Rev Fr Gynecol Obstet ; 89(7-9): 406-8, 1994.
Article in French | MEDLINE | ID: mdl-7973341

ABSTRACT

The final decade of the century confirms the importance of latest generation progestogens in terms of decreased risks associated with the use of doses of ethinyl estradiol of 50 gamma or more, equally effective in contraception of this type. These new combination very considerably limit the untoward effects seen in the past regarding carbohydrate and lipid metabolism, as well as cardiovascular disease. Concerning carcinogenesis, the long term protective effect against carcinomas of the endometrium and ovary is now accepted, while studies of breast cancer are not unanimous in their condemnation, the same applying to the risk of hepatocarcinoma. Regulation of cycles is satisfactory and the vaginal flora little affected. Moderate and stable fibroids seem to be well controlled, the same applying to mucosal hyperplasia. Pregnancy, particularly rare, is not influenced unfavourably and the effect on lactation appears to be nil. Provided that regular monitoring is ensured and contraindications are respected, age does not appear to be an absolute limiting factor to its use but the risk of concomitant smoking remains.


Subject(s)
Contraceptives, Oral, Combined/therapeutic use , Contraceptives, Oral, Hormonal/therapeutic use , Cardiovascular Diseases/chemically induced , Cardiovascular Diseases/epidemiology , Contraceptives, Oral, Combined/pharmacology , Contraceptives, Oral, Hormonal/pharmacology , Drug Monitoring , Female , Humans , Neoplasms/chemically induced , Neoplasms/epidemiology , Risk Factors , Smoking/adverse effects
3.
Chirurgie ; 118(1-2): 86-91, 1992.
Article in French | MEDLINE | ID: mdl-1306432

ABSTRACT

Six hundred twenty seven patients have been studied retrospectively to evaluate early complications after sewn or staples colonic anastomosis. Seventy four per cent of the patients underwent surgery because of malignant lesions and seventy seven per cent had an elective operation. Fourty seven per cent of the patients had a sewn anastomosis, 53% a stapled anastomosis. In elective surgery, most of the right hemicolectomies and partial proctocolectomies have been performed using stapler devices (p < 0.05). In emergency surgery, most of the anastomosis after partial and total colectomy have been hand sewn (p < 0.05). Operative mortality was 5.6%. It was significantly higher in older patients (> 80 years old) (p < 0.01) and after emergency operations (p < 0.0001). The rate of anastomotic leak was 3.7% and it was significantly higher after right hemicolectomy and partial proctocolectomies when anastomosis has been hand sewn compared to stapled anastomosis (p < 0.05). With regard to postoperative mortality, intra-abdominal abscess, intestinal obstruction, evisceration, pulmonary embolism and anastomotic stenosis 1.4% (global: after a 6 months follow-up) no significant differences have been observed between sewn and stapled anastomosis.


Subject(s)
Colonic Diseases/surgery , Rectal Diseases/surgery , Suture Techniques/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Anastomosis, Surgical/adverse effects , Colectomy , Female , Humans , Male , Middle Aged , Postoperative Complications , Proctocolectomy, Restorative , Retrospective Studies , Surgical Staplers , Survival Rate , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...